Search This Blog

Monday, January 25, 2021

Roth Capital Initiates Coverage On KemPharm with Buy Rating

 

Price Target of $28

https://www.benzinga.com/news/21/01/19293995/roth-capital-initiates-coverage-on-kempharm-with-buy-rating-announces-price-target-of-28

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)